Damora Therapeutics, Inc. (DMRA)
21.49
-0.52
(-2.36%)
USD |
NASDAQ |
Oct 30, 16:00
21.48
0.00 (0.00%)
After-Hours: 20:00
Damora Therapeutics Price to Book Value : 3.437 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 3.437 |
| October 29, 2026 | 3.521 |
| October 28, 2026 | 3.457 |
| October 27, 2026 | 3.513 |
| October 26, 2026 | 3.401 |
| October 23, 2026 | 3.374 |
| October 22, 2026 | 3.473 |
| October 21, 2026 | 3.444 |
| October 20, 2026 | 3.306 |
| October 19, 2026 | 3.082 |
| October 16, 2026 | 2.950 |
| October 15, 2026 | 2.998 |
| October 14, 2026 | 2.948 |
| October 13, 2026 | 2.969 |
| October 12, 2026 | 3.240 |
| October 09, 2026 | 3.372 |
| October 08, 2026 | 3.289 |
| October 07, 2026 | 3.238 |
| October 06, 2026 | 3.127 |
| October 05, 2026 | 3.234 |
| October 02, 2026 | 3.303 |
| October 01, 2026 | 3.236 |
| September 30, 2026 | 3.404 |
| September 29, 2026 | 3.305 |
| September 28, 2026 | 3.319 |
| Date | Value |
|---|---|
| September 25, 2026 | 3.305 |
| September 24, 2026 | 3.242 |
| September 23, 2026 | 3.270 |
| September 22, 2026 | 3.585 |
| September 21, 2026 | 3.655 |
| September 18, 2026 | 3.613 |
| September 17, 2026 | 3.644 |
| September 16, 2026 | 3.924 |
| September 15, 2026 | 3.959 |
| September 14, 2026 | 4.541 |
| September 11, 2026 | 4.495 |
| September 10, 2026 | 4.293 |
| September 09, 2026 | 4.202 |
| September 08, 2026 | 4.666 |
| September 04, 2026 | 4.808 |
| September 03, 2026 | 4.479 |
| September 02, 2026 | 4.508 |
| September 01, 2026 | 4.501 |
| August 31, 2026 | 4.508 |
| August 28, 2026 | 4.639 |
| August 27, 2026 | 4.895 |
| August 26, 2026 | 4.861 |
| August 25, 2026 | 4.898 |
| August 24, 2026 | 4.848 |
| August 21, 2026 | 4.930 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.712 |
| Alnylam Pharmaceuticals, Inc. | 6.129 |
| Anika Therapeutics, Inc. | 2.042 |
| Savara, Inc. | 6.891 |
| Vericel Corp. | 5.567 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0002 |
| Price | 21.49 |
| Earnings Yield | -580.7% |
| Market Cap | 1.327B |
| PEGY Ratio | -0.0002 |